This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Denk D, Bradtke J, Konig M, Strehl S. PAX5 fusion genes in t(7;9)(q11.2;p13) leukemia: a case report and review of the literature. Mol Cytogenet. 2014;7:13 https://doi.org/10.1186/1755-8166-7-13
Denk D, Nebral K, Bradtke J, Pass G, Moricke A, Attarbaschi A, et al. PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res. 2012;36:e178–181. https://doi.org/10.1016/j.leukres.2012.04.015
Coyaud E, Struski S, Dastugue N, Brousset P, Broccardo C, Bradtke J. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2; p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia. Leuk Res. 2010;34:e323–325. https://doi.org/10.1016/j.leukres.2010.07.035
Huret J. t(7;9)(q11; p12) PAX5/POM121. Atlas Genet Cytogenet Oncol Haematol. 2014;18:856–8.
Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G, et al. A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Blood. 2007;109:3417–23. https://doi.org/10.1182/blood-2006-05-025221.
Stasevich I, Inglott S, Austin N, Chatters S, Chalker J, Addy D, et al. PAX5 alterations in genetically unclassified childhood precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2015;171:263–72. https://doi.org/10.1111/bjh.13543
Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, et al. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood. 2010;115:3089–97. https://doi.org/10.1182/blood-2009-07-234229
Nebral K, Denk D, Attarbaschi A, Konig M, Mann G, Haas OA, et al. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia. 2009;23:134–43. https://doi.org/10.1038/leu.2008.306
Liao YC, Hsiao CT, Fuh JL, Chern CM, Lee WJ, Guo YC, et al. Characterization of CADASIL among the Han Chinese in Taiwan: distinct genotypic and phenotypic profiles. PLoS One. 2015;10:e0136501 https://doi.org/10.1371/journal.pone.0136501.
Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216–33. https://doi.org/10.1016/j.cell.2009.03.045.
Pelullo M, Quaranta R, Talora C, Checquolo S, Cialfi S, Felli MP, et al. Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL. Neoplasia. 2014;16:1007–17. https://doi.org/10.1016/j.neo.2014.10.004.
Pieper U, Webb BM, Dong GQ, Schneidman-Duhovny D, Fan H, Kim SJ, et al. ModBase, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res. 2014;42(Database issue):D336–346. https://doi.org/10.1093/nar/gkt1144.
Meng EC, Pettersen EF, Couch GS, Huang CC, Ferrin TE. Tools for integrated sequence-structure analysis with UCSF Chimera. BMC Bioinforma. 2006;7:339 https://doi.org/10.1186/1471-2105-7-339.
Else T, Theisen BK, Wu Y, Hutz JE, Keegan CE, Hammer GD, et al. Tpp1/Acd maintains genomic stability through a complex role in telomere protection. Chromosome Res. 2007;15:1001–13. https://doi.org/10.1007/s10577-007-1175-5.
Vlangos CN, O’Connor BC, Morley MJ, Krause AS, Osawa GA, Keegan CE. Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis. Dev Biol. 2009;334:418–28. https://doi.org/10.1016/j.ydbio.2009.07.038.
Guo Y, Kartawinata M, Li J, Pickett HA, Teo J, Kilo T, et al. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood. 2014;124:2767–74. https://doi.org/10.1182/blood-2014-08-596445.
Kocak H, Ballew BJ, Bisht K, Eggebeen R, Hicks BD, Suman S, et al. Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev. 2014;28:2090–102. https://doi.org/10.1101/gad.248567.114.
Spinella JF, Cassart P, Garnier N, Rousseau P, Drullion C, Richer C, et al. A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells. BMC Cancer. 2015;15:621 https://doi.org/10.1186/s12885-015-1639-5.
Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, et al. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nat Genet. 2002;32:645–9. https://doi.org/10.1038/ng1049.
Wang CQ, Chin DW, Chooi JY, Chng WJ, Taniuchi I, Tergaonkar V, et al. Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis. Leukemia. 2015;29:753–7. https://doi.org/10.1038/leu.2014.316.
Xiao H, Shi J, Luo Y, Tan Y, He J, Xie W, et al. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 2011;117:5257–60. https://doi.org/10.1182/blood-2010-12-326322.
Yasuda T, Ueno T, Fukumura K, Yamato A, Ando M, Yamaguchi H, et al. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia. 2014;28:426–8. https://doi.org/10.1038/leu.2013.278.
Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 1995;86:4579–86.
Neubauer A, Shannon K, Liu E. Mutations of the ras proto-oncogenes in childhood monosomy 7. Blood. 1991;77:594–8.
Wiseman DH, Das M, Poulton K, Liakopoulou E. Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine. Am J Hematol. 2011;86:315–8. https://doi.org/10.1002/ajh.21938.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Assi, R., Mahfouz, R., Owen, R. et al. PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia. Bone Marrow Transplant 54, 1124–1128 (2019). https://doi.org/10.1038/s41409-018-0419-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-018-0419-7
This article is cited by
-
A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype
Annals of Hematology (2023)
-
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
Bone Marrow Transplantation (2021)